Higher BASF bid alone will not win support for Evonik takeover, sources say
Resumen detallado
DUESSELDORF, Germany Nov 18 (Reuters) - A higher offer from German chemicals group BASF will not be enough to secure a takeover of smaller rival Evonik, two people close to Evonik…
DUESSELDORF, Germany Nov 18 (Reuters) - A higher offer from German chemicals group BASF will not be enough to secure a takeover of smaller rival Evonik, two people close to Evonik told Reuters on Wednesday, saying a deal would also need a compelling industrial rationale.
BASF first approached Evonik in September, but Evonik has resisted the advances and recently rejected a sweetened offer that valued the company at around €11.2 billion ($12.3 billion).
Their comments were echoed by Evonik's management, which in an internal memo circulated on Tuesday and seen by Reuters told employees it remained convinced the company had a strong future as a standalone business.
The comments by the two sources come after German business publication Handelsblatt, citing financial industry sources, reported that BASF would need to significantly raise its offer for Evonik, with a bid of €26 to €28 per share - or roughly €0.9 billion to €1.8 billion above the current offer - potentially helping to break the deadlock.
Evonik and BASF both declined to comment on the remarks from sources and the Handelsblatt report.
On Tuesday, people familiar with the matter told Reuters that BASF was preparing to offer greater concessions to Evonik in its latest attempt to secure support for the deal.
BASF has approached the state government in North Rhine-Westphalia, where Evonik is based, and Evonik's top shareholder, the RAG Foundation, with a letter offering possible commitments to plants, jobs and training, the people said.
However, North Rhine-Westphalia state premier Hendrik Wuest expressed scepticism on Wednesday about any potential takeover of Evonik by BASF.
"We stand by our decision that this company should continue to develop independently," he told a press conference.
Inicio del artículo, extracto de Euronext. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (live.euronext.com)
